Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy

OBJECTIVE: To evaluate whether quadrivalent human papillomavirus vaccine (4vHPV) administered during the periconceptional period or during pregnancy was associated with increased risks for adverse obstetric events, adverse birth outcomes, or selected major structural birth defects. METHODS: We condu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Obstet Gynecol
Autori principali: Lipkind, Heather S., Vazquez-Benitez, Gabriela, Nordin, James D., Romitti, Paul A., Naleway, Allison L., Klein, Nicola P., Hechter, Rulin C., Jackson, Michael L., Hambidge, Simon J., Lee, Grace M., Sukumaran, Lakshmi, Kharbanda, Elyse O.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496947/
https://ncbi.nlm.nih.gov/pubmed/28796684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000002191
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi